Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pol Specenier

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Journal of Geriatric Oncology|September 9, 2022
Functional status in older patients with cancer and a frailty risk profile: A multicenter observational studyGlen Meert, Cindy Kenis, Koen Milisen, et al.
Neuro-Oncology|February 24, 2016
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastomaAlba A Brandes, Antoine F Carpentier, Santosh Kesari, et al.
BMC Geriatrics|November 19, 2022
Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter studyCindy Kenis, Lore Decoster, Johan Flamaing, et al.
International Journal of Molecular Sciences|May 9, 2017
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and LomustineDavid Capper, Andreas von Deimling, Alba A Brandes, et al.
Trials|March 4, 2020
Study protocol for a randomized controlled trial: prophylactic swallowing exercises in head-and-neck cancer patients treated with (chemo)radiotherapy (PRESTO trial)Margot Baudelet, Leen Van den Steen, Fréderic Duprez, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 3, 2017
Feasibility of tongue strength measurements during (chemo)radiotherapy in head and neck cancer patientsLeen Van den Steen, Olivier Vanderveken, Jan Vanderwegen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2021
Tipifarnib in Head and Neck Squamous Cell Carcinoma With <i>HRAS</i> MutationsAlan L Ho, Irene Brana, Robert Haddad, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2021
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trialRachel Galot, Christophe Le Tourneau, Esma Saada-Bouzid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 11, 2020
Quantification of 18F-fluorodeoxyglucose uptake to detect residual nodal disease in locally advanced head and neck squamous cell carcinoma after chemoradiotherapy: results from the ECLYPS studyNils Helsen, Tim Van den Wyngaert, Laurens Carp, et al.
Head & Neck|February 23, 2019
Evolution of self-perceived swallowing function, tongue strength and swallow-related quality of life during radiotherapy in head and neck cancer patientsLeen Van den Steen, Dirk Van Gestel, Olivier Vanderveken, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Geriatric Oncology|September 9, 2022
Functional status in older patients with cancer and a frailty risk profile: A multicenter observational studyGlen Meert, Cindy Kenis, Koen Milisen, et al.
Neuro-Oncology|February 24, 2016
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastomaAlba A Brandes, Antoine F Carpentier, Santosh Kesari, et al.
BMC Geriatrics|November 19, 2022
Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter studyCindy Kenis, Lore Decoster, Johan Flamaing, et al.
International Journal of Molecular Sciences|May 9, 2017
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and LomustineDavid Capper, Andreas von Deimling, Alba A Brandes, et al.
Trials|March 4, 2020
Study protocol for a randomized controlled trial: prophylactic swallowing exercises in head-and-neck cancer patients treated with (chemo)radiotherapy (PRESTO trial)Margot Baudelet, Leen Van den Steen, Fréderic Duprez, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 3, 2017
Feasibility of tongue strength measurements during (chemo)radiotherapy in head and neck cancer patientsLeen Van den Steen, Olivier Vanderveken, Jan Vanderwegen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2021
Tipifarnib in Head and Neck Squamous Cell Carcinoma With <i>HRAS</i> MutationsAlan L Ho, Irene Brana, Robert Haddad, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2021
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trialRachel Galot, Christophe Le Tourneau, Esma Saada-Bouzid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 11, 2020
Quantification of 18F-fluorodeoxyglucose uptake to detect residual nodal disease in locally advanced head and neck squamous cell carcinoma after chemoradiotherapy: results from the ECLYPS studyNils Helsen, Tim Van den Wyngaert, Laurens Carp, et al.
Head & Neck|February 23, 2019
Evolution of self-perceived swallowing function, tongue strength and swallow-related quality of life during radiotherapy in head and neck cancer patientsLeen Van den Steen, Dirk Van Gestel, Olivier Vanderveken, et al.
Pageof 6